| 发明名称 |
METHOD FOR THE DIAGNOSIS OR PROGNOSIS, IN VITRO, OF LUNG CANCER |
| 摘要 |
The subject matter of the present invention is a method for the diagnosis or prognosis, in vitro, of lung cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, a method for use of said nucleic acid sequences, which have been isolated, as a molecular marker or molecular markers, and a kit including at least one binding partner specific for at least one of the expression products of the HERV nucleic acid sequences. |
| 申请公布号 |
US2015119265(A1) |
申请公布日期 |
2015.04.30 |
| 申请号 |
US201214367872 |
申请日期 |
2012.12.20 |
| 申请人 |
BIOMERIEUX |
发明人 |
Perot Philippe;Mallet François;Montgiraud Cécile;Mugnier Nathalie |
| 分类号 |
C12Q1/70;C12Q1/68 |
主分类号 |
C12Q1/70 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for the in vitro diagnosis or prognosis of lung cancer in a biological sample taken from a patient, which comprises a step of detecting at least one expression product of at least one nucleic acid sequence, said nucleic acid sequence being chosen from the sequences identified in SEQ ID NOs: 1 to 242 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOs: 1 to 242. |
| 地址 |
MARCY L'ETOILE FR |
